$AGIO Recent News Zacks Rank #5 Additions for Mo
Post# of 72709
Posted On: 03/10/2014 12:21:47 PM
$AGIO Recent News
Zacks Rank #5 Additions for Monday - Tale of the Tape 9:30 a.m. Today - Zacks.com
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 26.2% Higher - Tale of the Tape 10:18 a.m. March 7, 2014 - Zacks.com
Agios' CEO Discusses Q4 2013 Results - Earnings Call Transcript 12:23 p.m. March 6, 2014 - Seeking Alpha
Stocks You Wish You Owned on January 15 11:42 p.m. Jan. 16, 2014 - WallStreetSectorSelector
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 18.6% Higher - Tale of the Tape 10:21 a.m. Jan. 16, 2014 - Zacks.com
Celgene, Agios extend cancer collaboration 3:12 p.m. Dec. 11, 2013 - Seeking Alpha
Agios Presents Preclinical Data from Lead Programs at ASH 9:00 p.m. Dec. 9, 2013 - benzinga.com
Health-Care Stocks: Where to Find Value 7:08 a.m. Nov. 12, 2013 - Barrons.com
Agios Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 7:46 p.m. Nov. 9, 2013 - Seeking Alpha
The New Science Behind Medical Investing 4:27 a.m. Oct. 19, 2013 - Barrons.com
Pipeline Progress at Agios Pharma - Analyst Blog 12:10 p.m. Sept. 24, 2013 - Zacks.com
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 5:44 a.m. Sept. 23, 2013 - benzinga.com
Patients Share DNA for Cures 9:45 p.m. Sept. 16, 2013 - The Wall Street Journal Interactive Edition
How High Will Bluebird Bio Fly? 2:36 p.m. Sept. 12, 2013 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 4:32 p.m. Sept. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Packaged Goods Are Dead Money (8/28/13) 6:05 a.m. Aug. 29, 2013 - Seeking Alpha
Pound For Pound, Are Biotechs Still Worth Their Salt? 5:12 p.m. Aug. 23, 2013 - Investors Business Daily
UPDATE: Goldman Sachs Initiates Agios Pharmaceuticals with Buy on Emerging Leadership Position 9:22 a.m. Aug. 19, 2013 - benzinga.com
The New IPO Boom 3:46 p.m. Aug. 5, 2013 - Barrons.com
Agios Pharmaceuticals Closes Initial Public Offering, Underwriters Exercised Full Option 4:03 p.m. July 29, 2013 - benzinga.com
Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results 8:31 a.m. March 6, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call Discussing Fourth Quarter and Full Year 2013 Financial Results on March 6, 2014 6:25 p.m. Feb. 27, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference 9:01 a.m. Feb. 24, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Swann Global Healthcare Conference 9:01 a.m. Feb. 6, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Exercises Option to U.S. Development and Commercialization Rights for IDH1 Program under Celgene Collaboration 9:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 6, 2014 - BusinessWire
Additional Shares Purchased, Extended Collaboration, Credit Facility, Publication of Data, and Interim Results - Research Report on Karyopharm, Agios, Lannett, MacroGenics, and ZIOPHARM 9:00 a.m. Dec. 25, 2013 - PR Newswire
Agios Pharmaceuticals Added to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - BusinessWire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Agios Advances Cancer Metabolism Collaboration with Celgene 9:17 a.m. Dec. 11, 2013 - BusinessWire
Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting 8:00 p.m. Dec. 9, 2013 - BusinessWire
Agios Pharmaceuticals, Inc. [AGIO] to Ring The NASDAQ Stock Market Opening Bell 11:00 a.m. Nov. 22, 2013 - GlobeNewswire
Flagship VentureLabs(TM) Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome 9:30 a.m. Nov. 21, 2013 - PR Newswire
Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting 10:11 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results 9:00 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 7:30 a.m. Oct. 31, 2013 - BusinessWire
Flagship VentureLabs(TM) Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients 9:00 a.m. Oct. 22, 2013 - PR Newswire
Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference 6:30 a.m. Oct. 18, 2013 - BusinessWire
Agios Pharmaceuticals Added to Russell 2000(R), 3000(R) and Global Indexes 6:30 a.m. Oct. 1, 2013 - BusinessWire
Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors 6:30 a.m. Sept. 26, 2013 - BusinessWire
Zacks Rank #5 Additions for Monday - Tale of the Tape 9:30 a.m. Today - Zacks.com
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 26.2% Higher - Tale of the Tape 10:18 a.m. March 7, 2014 - Zacks.com
Agios' CEO Discusses Q4 2013 Results - Earnings Call Transcript 12:23 p.m. March 6, 2014 - Seeking Alpha
Stocks You Wish You Owned on January 15 11:42 p.m. Jan. 16, 2014 - WallStreetSectorSelector
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 18.6% Higher - Tale of the Tape 10:21 a.m. Jan. 16, 2014 - Zacks.com
Celgene, Agios extend cancer collaboration 3:12 p.m. Dec. 11, 2013 - Seeking Alpha
Agios Presents Preclinical Data from Lead Programs at ASH 9:00 p.m. Dec. 9, 2013 - benzinga.com
Health-Care Stocks: Where to Find Value 7:08 a.m. Nov. 12, 2013 - Barrons.com
Agios Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 7:46 p.m. Nov. 9, 2013 - Seeking Alpha
The New Science Behind Medical Investing 4:27 a.m. Oct. 19, 2013 - Barrons.com
Pipeline Progress at Agios Pharma - Analyst Blog 12:10 p.m. Sept. 24, 2013 - Zacks.com
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 5:44 a.m. Sept. 23, 2013 - benzinga.com
Patients Share DNA for Cures 9:45 p.m. Sept. 16, 2013 - The Wall Street Journal Interactive Edition
How High Will Bluebird Bio Fly? 2:36 p.m. Sept. 12, 2013 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 4:32 p.m. Sept. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Packaged Goods Are Dead Money (8/28/13) 6:05 a.m. Aug. 29, 2013 - Seeking Alpha
Pound For Pound, Are Biotechs Still Worth Their Salt? 5:12 p.m. Aug. 23, 2013 - Investors Business Daily
UPDATE: Goldman Sachs Initiates Agios Pharmaceuticals with Buy on Emerging Leadership Position 9:22 a.m. Aug. 19, 2013 - benzinga.com
The New IPO Boom 3:46 p.m. Aug. 5, 2013 - Barrons.com
Agios Pharmaceuticals Closes Initial Public Offering, Underwriters Exercised Full Option 4:03 p.m. July 29, 2013 - benzinga.com
Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results 8:31 a.m. March 6, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call Discussing Fourth Quarter and Full Year 2013 Financial Results on March 6, 2014 6:25 p.m. Feb. 27, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference 9:01 a.m. Feb. 24, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Swann Global Healthcare Conference 9:01 a.m. Feb. 6, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Exercises Option to U.S. Development and Commercialization Rights for IDH1 Program under Celgene Collaboration 9:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 6, 2014 - BusinessWire
Additional Shares Purchased, Extended Collaboration, Credit Facility, Publication of Data, and Interim Results - Research Report on Karyopharm, Agios, Lannett, MacroGenics, and ZIOPHARM 9:00 a.m. Dec. 25, 2013 - PR Newswire
Agios Pharmaceuticals Added to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - BusinessWire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Agios Advances Cancer Metabolism Collaboration with Celgene 9:17 a.m. Dec. 11, 2013 - BusinessWire
Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting 8:00 p.m. Dec. 9, 2013 - BusinessWire
Agios Pharmaceuticals, Inc. [AGIO] to Ring The NASDAQ Stock Market Opening Bell 11:00 a.m. Nov. 22, 2013 - GlobeNewswire
Flagship VentureLabs(TM) Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome 9:30 a.m. Nov. 21, 2013 - PR Newswire
Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting 10:11 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results 9:00 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 7:30 a.m. Oct. 31, 2013 - BusinessWire
Flagship VentureLabs(TM) Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients 9:00 a.m. Oct. 22, 2013 - PR Newswire
Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference 6:30 a.m. Oct. 18, 2013 - BusinessWire
Agios Pharmaceuticals Added to Russell 2000(R), 3000(R) and Global Indexes 6:30 a.m. Oct. 1, 2013 - BusinessWire
Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors 6:30 a.m. Sept. 26, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼